Latest news
JSPR DEADLINE - FINAL REMINDER: Bronstein, Gewirtz & Grossman LLC - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 06:47:33 GMTJasper Therapeutics Inc (JSPR) Stock News Today - TradingKeyTradingKey · Fri, 07 Aug 2026 19:43:35 GMTJSPR Q2'26 Earnings: EPS estimate is (0.25) USD - TradingViewTradingView · Thu, 06 Aug 2026 11:00:37 GMTBronstein, Gewirtz & Grossman, LLC Is Investigating Jasper Therap - The National Law ReviewThe National Law Review · Thu, 06 Aug 2026 10:37:28 GMTJasper Therapeutics, Inc. announced that it has received $131.999613 million in funding from a group of investors - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 11:57:33 GMTJasper Therapeutics (JSPR) completes $131.9M Rule 506(b) private equity sale - Stock TitanStock Titan · Tue, 04 Aug 2026 22:47:27 GMTJasper Therapeutics, Inc. (JSPR) awards 7,500 stock options to director - Stock TitanStock Titan · Tue, 04 Aug 2026 20:39:01 GMTJasper Therapeutics (JSPR) grants 7,500-share stock option to board director - Stock TitanStock Titan · Tue, 04 Aug 2026 20:11:41 GMT